Various complete remission rates in LRBA-deficient patients after treatment with abatacept according to dosing interval. A, The complete remission (CR) rates in patients received abatacept with one-week or two-weeks interval in comparison to four-weeks. C, The percentages of CR or partial remission (PR) rate in LRBA-deficient patients in terms of dose interval. ** p<.01, 1-way ANOVA test, * p<.05, Chi-square test.